A longitudinal study of functional brain complexity in progressive Alzheimer's disease

A longitudinal study of functional brain complexity in progressive Alzheimer's disease

Abstract INTRODUCTION Cross‐sectional resting‐state functional magnetic resonance imaging (rsfMRI) studies have revealed altered complexity with advanced Alzheimer's disease (AD) stages. The current study conducted longitudinal rsfMRI complexity analyses in AD. METHODS Linear mixed‐effects (LME...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ru Zhang, Leon Aksman, Dilmini Wijesinghe, John M. Ringman, Danny J. J. Wang, Kay Jann, for the Alzheimer's Disease Neuroimaging Initiative
Format:	Article
Language:	English
Published:	Wiley 2025-01-01
Series:	Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Subjects:	Alzheimer's disease complexity analysis functional magnetic resonance imaging longitudinal study mild cognitive impairment resting state
Online Access:	https://doi.org/10.1002/dad2.70059
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Forecasting the progression of Alzheimer's disease using neural networks and a novel preprocessing algorithm
by: Jack Albright, et al.
Published: (2019-01-01)

Early diagnosis of Alzheimer’s disease and mild cognitive impairment using MRI analysis and machine learning algorithms
by: Helia Givian, et al.
Published: (2024-12-01)

Longitudinal structural MRI-based deep learning and radiomics features for predicting Alzheimer’s disease progression
by: Sepehr Aghajanian, et al.
Published: (2025-08-01)

Resting-state functional magnetic resonance imaging study on cerebrovascular reactivity changes in the precuneus of Alzheimer’s disease and mild cognitive impairment patients
by: Xue Tang, et al.
Published: (2025-01-01)

The longitudinal effects of global and regional brain measurements on cognitive abilities
by: Fatemeh Hosseininasabnajar, et al.
Published: (2025-07-01)

CSF Amyloid-β42 associates with neuropsychiatric and cognitive outcomes via cerebral glucose metabolism
by: Ali Azargoonjahromi, et al.
Published: (2025-07-01)

Cognitive practice effects delay diagnosis of MCI: Implications for clinical trials
by: Mark Sanderson‐Cimino, et al.
Published: (2022-01-01)

Distinguishing Early from Late Mild Cognitive Impairment Using Magnetic Resonance Free-Water Diffusion Tensor Imaging
by: Maurizio Bergamino, et al.
Published: (2025-01-01)

Dissecting the clinical and pathological prognosis of MCI patients who reverted to normal cognition: a longitudinal study
by: Hai-Hong Yu, et al.
Published: (2025-05-01)

Computerized cognitive testing to capture cognitive decline in Alzheimer's disease: Longitudinal findings from the ARMADA study
by: Roos J. Jutten, et al.
Published: (2025-01-01)

The Greek Version of the Mild Behavioral Impairment Checklist (MBI-C): Psychometric Properties in Mild Cognitive Impairment Due to Alzheimer’s Disease
by: Efthalia Angelopoulou, et al.
Published: (2025-04-01)

Clinical and demographic factors modify the association between plasma phosphorylated tau‐181 and cognition
by: Corey J. Bolton, et al.
Published: (2024-10-01)

Cognitive Effect of Levetiracetam in Patients with Alzheimer’s Disease or Mild Cognitive Impairment: A Systematic Review
by: Mohamad Hosein Mohamadi, MD, et al.
Published: (2025-01-01)

An EEG-based framework for automated discrimination of conversion to Alzheimer’s disease in patients with amnestic mild cognitive impairment: an 18-month longitudinal study
by: Yingfeng Ge, et al.
Published: (2025-01-01)

Trajectory of plasma lipidome associated with the risk of late-onset Alzheimer's disease: a longitudinal cohort studyResearch in context
by: Tingting Wang, et al.
Published: (2025-08-01)

Dynamic changes and prognostic value of glutathione S-transferase alpha in mild cognitive impairment and Alzheimer’s disease
by: Yangyang Tang, et al.
Published: (2024-12-01)

Repetitive transcranial magnetic stimulation may promote the reversion of mild cognitive impairment to normal cognition
by: Zhiwei Guo, et al.
Published: (2025-04-01)

Olfactory Testing and Gray Matter Volume: A Combined Approach to Predict the Conversion to Alzheimer
by: Claudia Casadio, et al.
Published: (2025-03-01)

Detection of Alzheimer and mild cognitive impairment patients by Poincare and Entropy methods based on electroencephalography signals
by: Umut Aslan, et al.
Published: (2025-04-01)

Serotonin enhances neurogenesis biomarkers, hippocampal volumes, and cognitive functions in Alzheimer’s disease
by: Ali Azargoonjahromi, et al.
Published: (2024-12-01)

Incidence and Prevalence of Alzheimer’s Disease in Medicare Beneficiaries
by: Haixin Zhang, et al.
Published: (2024-12-01)

Alzheimer’s disease may develop from changes in the immune system, cell cycle, and protein processing following alterations in ribosome function
by: Akiko Yamakawa, et al.
Published: (2025-01-01)

Local gyrification index and sulcal depth as imaging markers of cognitive decline in Alzheimer’s disease
by: Yongsik Sim, et al.
Published: (2025-08-01)

Towards Clinical Diagnoses: Classifying Alzheimer's Disease Using Single fMRI, Small Datasets, and Transfer Learning
by: Samuel L. Warren, et al.
Published: (2025-03-01)

Machine learning–enhanced screening funnel for clinical trials in Alzheimer's disease
by: Scott Gladstein, et al.
Published: (2025-04-01)

Combination therapy targeting Alzheimer's disease risk factors is associated with a significant delay in Alzheimer's disease–related cognitive decline
by: Yuan Shang, et al.
Published: (2025-01-01)

Integrative network analysis reveals novel moderators of Aβ-Tau interaction in Alzheimer's disease
by: Akihiro Kitani, et al.
Published: (2025-04-01)

The relative efficiency of time‐to‐progression and continuous measures of cognition in presymptomatic Alzheimer's disease
by: Dan Li, et al.
Published: (2019-01-01)

Hypertension a Predictive Risk Factor on Progression to Alzheimer’s Disease Using APOEε4 as a Benchmark
by: Mingfei Li, et al.
Published: (2025-04-01)

Detection of Alzheimer’s Disease Using Hybrid Meta-ROI of MRI Structural Images
by: Xiaoming Zheng, et al.
Published: (2024-10-01)

Predicting episodic memory performance using different biomarkers: results from Argentina-Alzheimer&rsquo;s Disease Neuroimaging Initiative
by: Russo MJ, et al.
Published: (2016-09-01)

Plasma amyloid‐β oligomerization tendency as a potential predictor for conversion from mild cognitive impairment to Alzheimer's dementia: Findings from the GMCII cohort
by: Yuhan Xie, et al.
Published: (2025-01-01)

A systematic review and meta-analysis of pteridines in mild cognitive impairment and Alzheimer’s disease
by: Arduino A. Mangoni, et al.
Published: (2025-02-01)

The Alzheimer's Prevention Initiative Generation Program: Study design of two randomized controlled trials for individuals at risk for clinical onset of Alzheimer's disease
by: Cristina Lopez Lopez, et al.
Published: (2019-01-01)

Sarcopenia index is associated with Alzheimer’s disease, mild cognitive impairment and their mortality in Chinese adults aged 65 and older
by: Chenxi Ren, et al.
Published: (2025-07-01)

Sex‐specific composite scales for longitudinal studies of incipient Alzheimer's disease
by: Sarah J. Banks, et al.
Published: (2019-01-01)

Exercise intervention on the brain structure and function of patients with mild cognitive impairment: systematic review based on magnetic resonance imaging studies
by: Jing Xu, et al.
Published: (2024-12-01)

Correlating retinal and choroidal vascular parameters with volumetric MRI in Alzheimer’s disease and amnestic mild cognitive impairment
by: Wufan Zhao, et al.
Published: (2025-07-01)

Platform for the radiomics analysis of brain regions: The case of Alzheimer's disease and metabolic imaging
by: Ramin Rasi, et al.
Published: (2024-12-01)

Alzheimer's disease progression and risk factors: A standardized comparison between six large data sets
by: Stephanie Evans, et al.
Published: (2019-01-01)